Cullinan Oncology LLC

NASDAQ CGEM

Data sourced from iex and EODHD
Download Data

Cullinan Oncology LLC Income Statement 2012 - 2023

This table shows the Income Statement for Cullinan Oncology LLC going from 2012 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31
Revenue
M 0 0 19 19 0 0 0 0 0 0 -
Cost of Revenue
M 0 0 0 0 - - 0 0 0 0 -
Gross Profit
M 0 0 19 0 - - 0 0 0 0 -
Operating Expenses
M 190 -145 87 60 - - 0 0 0 1 -
Selling, General, and Administrative Expenses (SG&A)
M 42 40 29 17 5 5 0 0 0 0 0
Research and Development (R&D) Expenses
M 148 92 58 43 17 10 - - 0 - -
Other Operating Expenses
M 0 -277 0 0 - - - - 0 - -
Costs and Expenses
M 190 132 87 60 - - 0 0 0 1 -
Operating Income
M -191 145 -68 -60 -22 -15 0 0 0 -1 -
Interest Expense
M - 562 65 1 0 0 0 0 0 0 0
Non-operating Income/Expense
M 21 7 0 1 1 0 0 0 0 0 -
EBT
M -169 151 -67 -59 -22 -14 0 0 0 -1 -
Income Tax Provision
M -14 42 -2 -9 -2 0 0 0 0 0 -
Income after Tax
M -155 109 -65 -51 -20 -15 0 0 0 -1 -
Non-Controlling Interest
M - -2 0 -8 -1 0 0 0 0 0 -
Net Income
M - 111 -66 -52 -21 -14 0 0 0 -1 -
Shares (Basic, Weighted)
M - - - - - - - - - - -
Shares (Diluted, Weighted)
R 41,550,000.00 46,640,000.00 44,292,102.00 43,516,125.00 19,361,467.00 11,449,625.00 - - - - -
EBITDA
M -190 -409 -68 -60 -22 -15 - - - - -
Depreciation and Amortization
M 0 -554 0 0 0 0 - - - - -
EBIT
M -191 145 -68 -60 -22 -15 0 0 0 -1 -
Income from Discontinued Operations
M - - - - - - - - - - -
Tax Rate (Effective)
% 8.35 27.84 3.62 14.48 7.47 -2.80 0.00 0.00 0.00 0.00 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0 0 - - - - -
Gross Profit Margin
% - - 100.00 -0.33 - - - - - - -
Operating Income Margin
% - - -358.73 -318.51 - - - - - - -
Net Income Margin
% - - -346.14 -273.45 - - - - - - -
EBITDA Ratio
% - - -358.45 -318.18 - - - - - - -
EBIT Ratio
% - - -358.73 -318.51 - - - - - - -
EBT Ratio
% - - -356.25 -313.88 - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email